CI-980 for the Treatment of Recurrent or Progressive Malignant Gliomas: National Central Nervous System Consortium Phase I–II Evaluation of CI-980-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CI-980 for the Treatment of Recurrent or Progressive Malignant Gliomas: National Central Nervous System Consortium Phase I–II Evaluation of CI-980

Published:2002-01 Issue:7-8 Volume:20 Page:948-954
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Kunschner Lara J.,Fine Howard,Hess Kenneth,Jaeckle Kurt,Kyritsis Athanassios P.,Yung W. K. Alfred

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1081/CNV-120005910

Reference16 articles.

1. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas

2. A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future;Cancer Biology & Medicine;2018

2. Pyridine Based Antitumour Compounds Acting at the Colchicine Site;Current Medicinal Chemistry;2016-04-20

3. Translational Gap in Glioma Research;Anti-Cancer Agents in Medicinal Chemistry;2014-08-25

4. The role of targeted therapies in the management of progressive glioblastoma;Journal of Neuro-Oncology;2014-04-17

5. Central nervous system tumors;Cancer Chemotherapy and Biological Response Modifiers Annual;2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP